NGeneBio Co., Ltd. (KOSDAQ: 354200)
South Korea
· Delayed Price · Currency is KRW 1,683.00
+27.00 (1.63%)
Jan 22, 2025, 3:00 PM KST
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 33.35 billion as of January 22, 2025. Its market cap has decreased by -53.29% in one year.
Market Cap
33.35B
Enterprise Value
41.70B
Revenue
6.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,683.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 33.35B, a decrease of -89.35%. That is a compound annual growth rate of -41.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 33.35B | 2.91% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | 379.90B | 21.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 355.59T |
| SK hynix | 150.21T |
| LG Energy Solution | 82.95T |
| Samsung Biologics Co.,Ltd. | 71.25T |
| Hyundai Motor Company | 45.49T |
| Kia Corporation | 39.35T |
| Celltrion | 38.12T |
| KB Financial Group | 33.29T |